Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
Blocking Rac1 protein may prevent nerve damage in hATTR-PN: Lab study
Feb 16, 2026
News
Leukaemia Foundation PhD Scholarship
Mar 09, 2026
Fluid Balance in Amyloidosis: Why Too Much or Too Little Can Harm Table of Contents
Feb 27, 2026
New AL-ISS Model Validated for Prognosis in AL Amyloidosis
Feb 26, 2026
A Spatial Proteomics Approach to Isolate and Analyze Amyloid Proteins Using Laser Capture Microdissection and Mass Spectrometry
Feb 26, 2026
Refold Therapeutics acquires exclusive global license rights from UCB to research, develop and commercialize antibody constructs targeting free light chain in amyloidosis and cancer
Feb 24, 2026
More in News
Education
Clinical Features of Systemic Amyloidosis: A Scoping Review
Jan 27, 2026
AL Cardiac Amyloidosis Presenting as Grade 3 ATTR Mimicry on Scintigraphy
Jan 23, 2026
https://www.oreateai.com/blog/understanding-hattr-a-deep-dive-into-hereditary-transthyretin-amyloidosis/23903414f6a0a602d9aca557d23f138c
Jan 21, 2026
AL Cardiac Amyloidosis Presenting as Grade 3 ATTR Mimicry on Scintigraphy
Jan 21, 2026
How to Manage Nerve Damage if You Have ATTR-CM
Jan 20, 2026
More in Education
Community Center
The “Mixed Phenotype” Mystery: Why Your hATTR Diagnosis Might Only Be Half the Story
Jan 28, 2026
How Rare Cancer Saved My Life
Jan 15, 2026
My Journey with Amyloidosis: Turning Fear into Purpose
Jan 15, 2026
My Amyloid Story Christine Giosa
Jan 15, 2026
A Second Chance at Life: Gurmit’s Story
Jan 13, 2026
More in Community Center
Video